SINOMED(SH:688108) Sou Hu Cai Jing·2025-08-19 11:47Core Viewpoint - Sino Medical reported a closing price of 40.42 yuan, down 2.56%, with a rolling PE ratio of 2738.89 times and a total market value of 16.817 billion yuan [1] Company Overview - Sino Medical Technology Co., Ltd. specializes in the research, development, production, and sales of high-end interventional medical devices [1] - The main products include biodegradable drug-coated coronary stent systems, drug-eluting stent systems, non-compliant PTCA balloon dilatation catheters, and various other interventional devices [1] Financial Performance - For Q1 2025, the company achieved an operating income of 101 million yuan, a year-on-year increase of 10.75%, and a net profit of 2.9693 million yuan, a year-on-year increase of 277.50% [2] - The sales gross margin stood at 59.66% [2] Market Position - The average PE ratio for the medical device industry is 59.49 times, with a median of 40.19 times, placing Sino Medical at the 123rd position in the industry ranking [1] - The company's static PE ratio is 11227.62 times, and the price-to-book ratio is 19.32 [2] Shareholder Information - As of March 31, 2025, Sino Medical had 11,044 shareholders, an increase of 381 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1]